REINSNOS AS
Keywords
specialsomaticdiseasescancerlung diseasesrheumatism
Organization
- CEO
- IR
- Chairman of the board
- IR
- Years since formation
- 30 years
- since Feb 19, 1995
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 50
- 1 share class
- Total number of shareholders
- 2
- persons
- Belongs to group of
Financials
- Total operating income 2024
- 3,197,791
- NOK
- Annual total result 2024
- 3,183,621
- NOK
- Total equity 2024
- 13,111,438
- NOK
Last update: Sep 9, 2025
Management
Management / administration
Name | Role | Shares |
---|---|---|
IR | Managing Director/CEO | 50 % directly |
Board
Name | Role | Shares |
---|---|---|
IR | Chairman | 50 % directly |
Others
Name | Role | Shares |
---|---|---|
Auditor | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
IR | Managing Director/CEO, Chairman | 50 % directly |
MR | - | 50 % directly |
Last update: Dec 6, 2024
Ownership
Company shareholders
Name | Share class | Total number of shares | Share |
---|---|---|---|
IR | Ordinary shares | 25 | 50 % |
MR | Ordinary shares | 25 | 50 % |
Shares owned by the REINSNOS AS
Name | Share class | Total number of shares | Share |
---|---|---|---|
Ordinary shares | 30 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 3,197,791Operating profit 2024: NOK 2,566,337Employees: 0
Financials
in NOK
Summary
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 3,197,791 | 1,345,716 | 1,129,663 | 940,776 |
Annual Total Result | 3,183,621 | 440,032 | 321,323 | 415,204 |
Total assets | 16,879,678 | 16,841,377 | 13,081,104 | 13,499,889 |
Total liabilities | 3,768,240 | 6,913,559 | 3,093,318 | 3,133,426 |
Total equity | 13,111,438 | 9,927,818 | 9,987,786 | 10,366,463 |
P&L
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 3,197,791 | 1,345,716 | 1,129,663 | 940,776 |
Total operating costs | 631,454 | 612,585 | 640,219 | 365,738 |
Operating result | 2,566,337 | 733,132 | 489,444 | 575,038 |
Financial income/costs | 1,515,230 | -169,170 | -77,521 | -42,725 |
Profit before tax | 4,081,567 | 563,962 | 411,923 | 532,313 |
Total tax & extraordinary income/cost | 897,946 | 123,930 | 90,600 | 117,109 |
Annual Total Result | 3,183,621 | 440,032 | 321,323 | 415,204 |
Balance overview
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total fixed assets | 12,454,303 | 14,224,142 | 10,375,892 | 10,381,539 |
Total current assets | 4,425,375 | 2,617,235 | 2,705,211 | 3,118,350 |
Total assets | 16,879,678 | 16,841,377 | 13,081,104 | 13,499,889 |
Short term debt | 3,372,880 | 3,963,767 | 3,079,002 | 3,093,940 |
Long term debt | 395,360 | 2,949,792 | 14,316 | 39,486 |
Total liabilities | 3,768,240 | 6,913,559 | 3,093,318 | 3,133,426 |
Contributed capital | 108,401 | 108,401 | 108,401 | 108,401 |
Retained earnings | 13,003,037 | 9,819,417 | 9,879,385 | 10,258,062 |
Total equity | 13,111,438 | 9,927,818 | 9,987,786 | 10,366,463 |
Total equity and liabilities | 16,879,678 | 16,841,377 | 13,081,104 | 13,499,889 |
Classification
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.1
Main industrial group
Hospital activities
86.10
Industrial group
Hospital activities
86.102
Industrial group
Specialised hospitals